Skip to main content
. 2017 Dec 22;8:2557. doi: 10.3389/fmicb.2017.02557

Figure 1.

Figure 1

HBMECs are productively infected by ZIKV. (A) HBMECs were mock treated or infected with ZIKVPE243 or ZIKVMR766, at the indicated MOI. After 48 h, cells were stained with 4G2 antibody and analyzed by immunofluorescence. (B,C) HBMECs were infected with ZIKVPE243 or ZIKVMR766 (MOI 1), produced in C6/36 cells (B) or produced in Vero cells (C). After different time points, supernatants were harvested and viral RNA was measured by qRT-PCR. (D,E) HBMECs were infected with ZIKVPE243 or ZIKVMR766 (MOI 1), produced in C6/36 cells (D) or produced in Vero cells (E). After different time points, supernatants were harvested and infectious particles were titrated by plaque assay. Data are represented as mean ± SD of two independent experiments.